SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-024710
Filing Date
2023-03-30
Accepted
2023-03-30 16:54:59
Documents
79
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_chinapharma.htm   iXBRL 10-K 1183097
2 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY FILED WITH THE STA f10k2022ex3-1_china.htm EX-3.1 5292
3 LOANS EXTENSION CONFIRMATION LETTER, DATED DECEMBER 31, 2022, BETWEEN THE COMPAN f10k2022ex10-11_china.htm EX-10.11 3332
4 CONSENT OF THE INDEPENDENT ACCOUNTING FIRM f10k2022ex23-1_china.htm EX-23.1 2011
5 CERTIFICATION f10k2022ex31-1_china.htm EX-31.1 10921
6 CERTIFICATION f10k2022ex31-2_china.htm EX-31.2 11088
7 CERTIFICATION f10k2022ex32-1_china.htm EX-32.1 5608
8 GRAPHIC image_001.jpg GRAPHIC 14163
9 GRAPHIC ex3-1_001.jpg GRAPHIC 299264
10 GRAPHIC ex3-1_002.jpg GRAPHIC 221443
11 GRAPHIC ex3-1_003.jpg GRAPHIC 267227
12 GRAPHIC ex3-1_004.jpg GRAPHIC 53493
13 GRAPHIC ex3-1_005.jpg GRAPHIC 285994
14 GRAPHIC ex3-1_006.jpg GRAPHIC 213133
  Complete submission text file 0001213900-23-024710.txt   7297652

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE cphi-20221231.xsd EX-101.SCH 57961
16 XBRL CALCULATION FILE cphi-20221231_cal.xml EX-101.CAL 39002
17 XBRL DEFINITION FILE cphi-20221231_def.xml EX-101.DEF 245846
18 XBRL LABEL FILE cphi-20221231_lab.xml EX-101.LAB 503466
19 XBRL PRESENTATION FILE cphi-20221231_pre.xml EX-101.PRE 258929
73 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_chinapharma_htm.xml XML 486182
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34471 | Film No.: 23781449
SIC: 2834 Pharmaceutical Preparations